TherapeuticsMD, Inc.
TXMD
$2.02
-$0.18-8.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.48M | 7.12M | 6.07M | 5.75M | 5.06M |
| Total Receivables | 4.20M | 3.67M | 3.74M | 3.00M | 4.10M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 89.00K | 175.00K | 168.00K | 231.00K | 70.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.68M | 3.55M | 3.48M | 3.54M | 3.03M |
| Total Current Assets | 14.45M | 14.50M | 13.46M | 12.51M | 12.26M |
|
|
|||||
| Total Current Assets | 14.45M | 14.50M | 13.46M | 12.51M | 12.26M |
| Net Property, Plant & Equipment | 5.29M | 5.52M | 5.73M | 5.95M | 6.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.76M | 3.91M | 4.04M | 4.14M | 4.32M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.16M | 14.74M | 15.27M | 15.64M | 16.14M |
| Total Assets | 37.66M | 38.67M | 38.50M | 38.24M | 38.82M |
|
|
|||||
| Total Accounts Payable | 377.00K | 263.00K | 350.00K | 176.00K | 258.00K |
| Total Accrued Expenses | 766.00K | 943.00K | 704.00K | 769.00K | 494.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 975.00K | 1.07M | 886.00K | 1.01M | 1.63M |
| Total Finance Division Other Current Liabilities | 2.67M | 2.67M | 2.72M | 2.79M | 2.78M |
| Total Other Current Liabilities | 2.67M | 2.67M | 2.72M | 2.79M | 2.78M |
| Total Current Liabilities | 4.79M | 4.95M | 4.66M | 4.74M | 5.17M |
|
|
|||||
| Total Current Liabilities | 4.79M | 4.95M | 4.66M | 4.74M | 5.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.12M | 5.41M | 5.72M | 5.96M | 5.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 873.00K | 871.00K | 832.00K | 795.00K | 744.00K |
| Total Liabilities | 10.78M | 11.23M | 11.21M | 11.50M | 11.45M |
|
|
|||||
| Common Stock & APIC | 979.27M | 979.22M | 979.22M | 979.22M | 979.19M |
| Retained Earnings | -952.39M | -951.77M | -951.92M | -952.48M | -951.82M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 26.88M | 27.44M | 27.29M | 26.74M | 27.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.88M | 27.44M | 27.29M | 26.74M | 27.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.88M | 27.44M | 27.29M | 26.74M | 27.37M |
|
|
|||||